BIOAGE LABS INC (BIOA:NASDAQ)
$16.19 -1.6 (-8.9938%)
Analysed BIOAGE LABS INC (BIOA:NASDAQ) News Sources
Is Amgen (AMGN) Outperforming Other Medical Stocks This Year?
07-04-2026
yahoo.com
BGE-102 Data Inspires Confidence for BioAge Labs (BIOA)
31-03-2026
yahoo.com
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025
24-03-2026
yahoo.com
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress
23-03-2026
yahoo.com
BioAge Labs Touts Oral NLRP3 Inhibitor BGE-102 Data, Eyes CV Study and Retinal Expansion
27-02-2026
marketbeat.com
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
19-02-2026
yahoo.com
BLA for subcutaneous formulation of Leqembi® designated for Priority Review in China
09-02-2026
yahoo.com
Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential
29-01-2026
pharmavoice.com
BioAge Announces Pricing of Upsized $115.0 Million Public Offering
22-01-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Amid Continued Tariff Threats, Investors Await President Trump's Speech at Davos
21-01-2026
yahoo.com
What is the current price of BIOAGE LABS INC (BIOA:NASDAQ)?
The current price of BIOAGE LABS INC (BIOA:NASDAQ) is $16.19.
BIOAGE LABS INC (BIOA:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOAGE LABS INC (BIOA:NASDAQ) since the previous trading day is $-1.6.
BIOAGE LABS INC (BIOA:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOAGE LABS INC (BIOA:NASDAQ) since the previous trading day is -8.9938%.
What is the most recent average sentiment score for BIOAGE LABS INC (BIOA:NASDAQ)?
The most recent average sentiment score for BIOAGE LABS INC (BIOA:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for BIOAGE LABS INC (BIOA:NASDAQ)?
The most recent sentiment for BIOAGE LABS INC (BIOA:NASDAQ) is .
SEC-8K** Filing Available For BIOAGE LABS INC (BIOA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.